The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 24, 2024
Filed:
Oct. 11, 2018
Applicant:
Setpoint Medical Corporation, Valencia, CA (US);
Inventors:
Jacob A. Levine, West Hempstead, NY (US);
Nicole Hamlin, Centereach, NY (US);
David Chernoff, Valencia, CA (US);
Assignee:
SetPoint Medical Corporation, Valencia, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 1/36 (2006.01); A61B 5/388 (2021.01); A61B 5/00 (2006.01); A61B 5/01 (2006.01); A61B 5/145 (2006.01); A61N 1/04 (2006.01); A61N 1/05 (2006.01); A61N 1/08 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
A61N 1/36053 (2013.01); A61B 5/388 (2021.01); A61N 1/36175 (2013.01); A61B 5/01 (2013.01); A61B 5/145 (2013.01); A61B 5/4029 (2013.01); A61B 5/4041 (2013.01); A61B 5/4076 (2013.01); A61B 5/4842 (2013.01); A61B 5/6877 (2013.01); A61N 1/0456 (2013.01); A61N 1/0556 (2013.01); A61N 1/08 (2013.01); A61N 1/36064 (2013.01); A61N 1/36067 (2013.01); A61N 1/36082 (2013.01); A61N 1/36103 (2013.01); C12Q 2600/158 (2013.01); G01N 33/6896 (2013.01); G01N 2333/78 (2013.01); G01N 2800/2835 (2013.01); G01N 2800/285 (2013.01); G01N 2800/52 (2013.01); G01N 2800/7095 (2013.01);
Abstract
Systems, devices, and methods for using vagus nerve stimulation to treat demyelination disorders and/or disorder of the blood brain barrier are described. The vagus nerve stimulation therapy described herein is configured to reduce or prevent demyelination and/or promote remyelination to treat various disorders related to demyelination, such as multiple sclerosis. A low duty cycle stimulation protocol with a relatively short on-time and a relatively long off-time can be used.